SCI-TECH

Tederox and Padynex: Iran’s entry into elite club of antibody-drug conjugate manufacturing

Iran joins elite ADC-producing countries with Tederox and Padynex, cutting costs by over 90 percent, expanding HER2-positive cancer treatment access, and showcasing rapid biopharmaceutical advancement despite sanctions.